Medicinal Chemistry
A section of Molecules (ISSN 1420-3049).
Section Information
The Medicinal Chemistry Section of the journal Molecules publishes original research and review articles that increase our understanding of how the chemical structure of bioactive molecules determines their pharmacodynamic, pharmacokinetic, and physicochemical properties and, hence, their therapeutic potential. In particular, this Section mainly invites contributions that report on:
-The design, synthesis, chemical characterization1, and biological evaluation of novel compounds against biological targets of therapeutic, diagnostic, or theranostic interest, and/or the assessment of their physicochemical and pharmacokinetic properties;
-The isolation from herbal plants and separate biological characterization of individual bioactive compounds and/or their semisynthetic derivatives;
-Hit-to-lead projects that lead to a significant optimization of potency, or physicochemical and/or pharmacokinetic properties;
-Computational2, molecular biology, and/or structural biology studies that shed light on the structure and function of biological targets of therapeutic, diagnostic, or theranostic interest and on their interaction with known or novel compounds, thereby enabling the rational design of optimized ligands;
-Computational2 and biological studies of known drugs or their derivatives that address their interaction with novel biological targets for repositioning purposes;
-Novel synthetic, computational2, or biological methodologies of relevance in medicinal chemistry;
-Development and application of materials for medicinal chemistry purposes, such as drug delivery and drug targeting.
Manuscripts that report on the biological evaluation of mixtures of compounds, such as plant extracts, or purely pharmacological studies that look deeper into the standard action of well-established drugs will normally not be considered for publication in this Section.
1 Authors are encouraged to present additional data and files about the purity and characterization of new compounds that are auxiliary to the main content of the article. The goal is to keep the main body of the article concise but also provide detailed information that increases reproducibility and availability of presented research. Examples include (but are not limited to) NMR spectra, or routine preparations of substrates. All new entities must be fully characterized by appropriate analytical methods with sufficient evidence for composition, structure, and purity. The identity and bulk purity of compounds and materials should be verified with elemental analysis or other appropriate methods.
2 Manuscripts that mainly describe computational studies need to be accompanied by experimental validation. For QSAR modeling, a sufficient number of new compounds should be included and discussed. As with chemical and biological methods, authors should present sufficient information to allow computational methods to be reproduced and tested in other laboratories.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Food Waste and Circular Bioeconomy: New Nutraceutical and Pharmaceutical (Deadline: 15 July 2022)
- New Aspects of Pharmacology and Toxicology of Antibacterial Drugs (Deadline: 31 July 2022)
- Drug Design: Science and Practice (Deadline: 31 July 2022)
- Metal Complexes in the Treatment of Disease (Deadline: 31 July 2022)
- Small Molecule Inhibitors of Polymerases Involved in Human Diseases (Deadline: 31 July 2022)
- Natural Products: Isolation, Identification and Biological Activity (Deadline: 31 July 2022)
- Bioactive Compounds in Metabolic Syndrome Tug-of-War (Deadline: 31 July 2022)
- Recent Advances in Heterocyclic Chemistry in Drug Discovery (Deadline: 31 July 2022)
- Medicinal Chemistry in Europe III (Deadline: 31 July 2022)
- Drug Development for Neurodegenerative Diseases (Deadline: 31 July 2022)
- Integrated and Multidisciplinary Approach to Manage Metabolic Diseases (Deadline: 31 July 2022)
- Heterocyclic Building Blocks for Medicinal Applications (Deadline: 31 July 2022)
- Drug Discovery and Development: New Options for Old Diseases (Deadline: 31 July 2022)
- Nanomedicine Based Drug Delivery Systems: Recent Developments and Future Prospects (Deadline: 31 July 2022)
- Advances of Molecular Sciences in Regenerative Dentistry (Deadline: 31 July 2022)
- Molecular Modelling and Simulations of Membrane Proteins (Deadline: 31 July 2022)
- Novel Agents in Photodynamic Therapy (Deadline: 31 July 2022)
- Role of Computer Aided Drug Design in Drug Development (Deadline: 31 July 2022)
- Novel Anticancer Therapies Targeting Stem Cells (Deadline: 31 July 2022)
- The Fantastic World of Free Radicals and Antioxidants: A Themed Issue Dedicated to Professor Dr. Etsuo Niki (Deadline: 31 July 2022)
- Site-Directed Radiopeptides: Design and Applications in Medicine (Deadline: 31 July 2022)
- Fluorescent Probes as Powerful Tools in Medicinal Chemistry (Deadline: 31 July 2022)
- Targeting Innovation in Medicinal Chemistry (Deadline: 31 July 2022)
- Lipids in Drug Delivery and Therapeutics (Deadline: 31 July 2022)
- Covalent Inhibitors in Drug Discovery and Chemical Biology (Deadline: 31 July 2022)
- Isoxazolines in Medicinal Chemistry and Natural Products (Deadline: 31 July 2022)
- Anti-Inflammatory Drug as a Treatment for Psychiatric Disorders (Deadline: 31 July 2022)
- Carbonic Anhydrases-Chemistry and Biomedical Applications (Deadline: 31 July 2022)
- Repurposing Drugs and Molecules with Anti-cancer and Immunomodulatory Effects (Deadline: 31 July 2022)
- Recent Progress in the Development of Steroid Sulfatase Inhibitors (Deadline: 1 August 2022)
- Data and Low-Data Tools for Artificial Intelligence in Medicinal Chemistry (Deadline: 15 August 2022)
- Fragment-to-Lead Optimization in Drug Discovery (Deadline: 15 August 2022)
- Recent Trends on Enzymes Inhibitors and Activators in Drug Research 3.0 (Deadline: 20 August 2022)
- Molecular Toxicology and Cancer Prevention (Deadline: 31 August 2022)
- Novel Design and Synthesis of Anticancer Agents (Deadline: 31 August 2022)
- Design, Synthesis and Structure-Activity Relationship of Small-Molecule Inhibitors (Deadline: 31 August 2022)
- Nano Based Drug Delivery: Challenges, Opportunities and Innovation (Deadline: 31 August 2022)
- Heterocyclic Chemistry in the Footsteps of the Graoully—In Honour of Gilbert Kirsch on the Occasion of His 75th Birthday (Deadline: 31 August 2022)
- Perspective in Synthetic Medicinal Chemistry (Deadline: 31 August 2022)
- Researches on Novel Antibacterial Agents (Deadline: 31 August 2022)
- Nanotechnology in Medicinal Chemistry: Towards a New Era (Deadline: 31 August 2022)
- Ruthenium Complexes as Anticancer Drugs (Deadline: 31 August 2022)
- Nitric Oxide Donors for Biomedical Applications: A Themed Issue Dedicated to Professor Alberto Gasco (Deadline: 31 August 2022)
- Carbohydrate Metabolism as Target in Infectious Disease (Deadline: 31 August 2022)
- Contribution of Drug Metabolizing Enzymes and Transporters to Drug-Drug Interactions (Deadline: 15 September 2022)
- Opioids and Their Receptors (Deadline: 15 September 2022)
- Synthesis and Identification of Small Compounds Active in Neurodegeneration, Part II (Deadline: 15 September 2022)
- Targeted Anticancer Drug Discovery (Deadline: 15 September 2022)
- Biofunctional Molecule Exploratory Research on Application in Food and Health (Deadline: 15 September 2022)
- Antiproliferative and Anti-inflammatory Drugs (Deadline: 23 September 2022)
- Computational Approaches in Drug Discovery and Design (Deadline: 28 September 2022)
- Phytochemistry and Biological Properties of Medicinal Plants (Deadline: 30 September 2022)
- Inorganic Compounds in Medicine, Cancer Therapy and Beyond – an Update from Drug Design Perspective (Deadline: 30 September 2022)
- Addressing Neurodegenerative Disorders with Monoamine Oxidase and Cholinesterase Inhibitors (Deadline: 30 September 2022)
- Synthesis and Evaluation of Biologically Active Compounds from Heterocycles Class (Deadline: 30 September 2022)
- Metal-Based Drugs: Past, Present and Future (Deadline: 30 September 2022)
- Computational Chemistry of Pharmaceutical and Biomolecules (Deadline: 30 September 2022)
- Natural Compounds for the Treatment of Cardiovascular Diseases (Deadline: 30 September 2022)
- The Current Landscape of Nucleic-Acid-Based Drugs (Deadline: 30 September 2022)
- New Potential Antimicrobial Agents: Design, Synthesis and Biological Evaluation (Deadline: 30 September 2022)
- In Honor of Prof. Dr. Fernanda Borges’s Contribution (Deadline: 30 September 2022)
- Polyamine Drug Discovery (Deadline: 30 September 2022)
- Zebrafish-Based Drug Discovery (Deadline: 30 September 2022)
- New Drugs against Tuberculosis and Mycobacterium abscessus Infections (Deadline: 30 September 2022)
- Nanoparticles in Cellular Drug Delivery (Deadline: 30 September 2022)
- Veterinary Drugs (Deadline: 30 September 2022)
- Medicinal Chemistry Studies of Neglected Diseases (Deadline: 30 September 2022)
- Potential Application of Small Molecules in Molecular Medicine–an In Vitro and In-Silico Approach (Deadline: 30 September 2022)
- Nanoscale Bioconjugates for Advanced Drug Delivery (Deadline: 30 September 2022)
- Advances in Anti-infective Drug Discovery (Deadline: 30 September 2022)
- Natural Products as Sources of New Drugs: In Memory of Professor Kuo-Hsiung Lee (1940-2021) (Deadline: 30 September 2022)
- Anticancer Drug Discovery and Development II (Deadline: 30 September 2022)
- Molecular-Targeted Cancer Therapy (Deadline: 30 September 2022)
- Medicinal Plants and Industrial Crops: Phytochemistry and Metabolic Diseases (Deadline: 30 September 2022)
- Design, Synthesis and Applications of New Anti-cancer Agents II (Deadline: 30 September 2022)
- Novel Strategies for the Prevention and Treatment of Cardiovascular Diseases: New Horizons from Pharmaceuticals to Nutraceuticals (Deadline: 30 September 2022)
- Therapy of Neurodegenerative Diseases in Medicinal Chemistry (Deadline: 30 September 2022)
- Biologically Active Heterocyclic Compounds (Deadline: 30 September 2022)
- Radiolabeled Compounds for Cancer (Deadline: 1 October 2022)
- Nanomaterials for Biomedical Applications: From Diagnostics and Drug Delivery to Biosensing and Theragnostics (Deadline: 1 October 2022)
- Development and Research of Novel Drugs on Oncolytic Viruses and Cancer Immunotherapy (Deadline: 1 October 2022)
- Discovery of Bioactive Compounds for Inflammatory Diseases (Deadline: 15 October 2022)
- Progress and Perspective of Antiviral Agents (Deadline: 15 October 2022)
- Understanding the Redox Aspects of Anti-epileptic Drug Therapy (Deadline: 15 October 2022)
- Computational Virtual Screening Towards Designing Novel Anticancer Drugs (Deadline: 15 October 2022)
- Natural Product Chemistry in Drug Discovery (Deadline: 25 October 2022)
- Bioelements and Bioactive Metabolites of Natural Origin—Health-Promoting Applications (Deadline: 30 October 2022)
- Diabetes: What Roles Does DPP4 Inhibition Have? (Deadline: 31 October 2022)
- Opportunities and Challenges of Organic Synthesis in Drug Discovery (Deadline: 31 October 2022)
- Fluorine in Imaging toward Biological and Medical Applications (Deadline: 31 October 2022)
- Synthetic Efforts and Nature Winks: Recent Advances in the Discovery of Biologically Relevant Small Molecules (Deadline: 31 October 2022)
- Natural Medicines: Chemical Constituents and Pharmacological Activities (Deadline: 31 October 2022)
- Current Advances in the Discovery and Development of New Therapies against Cancer (Deadline: 31 October 2022)
- Secondary Metabolites for the Reduction of Oxidative Stress (Deadline: 31 October 2022)
- Design, Synthesis and Bioactivity Evaluation of Target-Based Antiviral Drugs (Deadline: 31 October 2022)
- Biocatalysis and Enzymes in Pharmaceutical and Biotechnological Processes (Deadline: 31 October 2022)
- Practical Applications of Chemoinformatics in Medicinal Chemistry and Drug Discovery (Deadline: 31 October 2022)
- Small Molecules as Anticancer Drugs: Successes, Challenges, and Opportunities (Deadline: 31 October 2022)
- Recent Advances in Molecular Imaging (Deadline: 31 October 2022)
- Natural Compounds and Chemical Compounds in Cancer Treatment (Deadline: 31 October 2022)
- Applications of Computational Chemistry Methods in Viral Diseases Research (Deadline: 31 October 2022)
- Design, Synthesis, and Analysis of Potential Drugs, 2nd Edition (Deadline: 31 October 2022)
- Carbohydrate Based Small Molecules: Sweet Spots in Medicinal Chemistry (Deadline: 31 October 2022)
- Novel Antibacterial Agents: Discovery, Design, Synthesis, and Evaluation (Deadline: 31 October 2022)
- Antibody-Drug Conjugates: An Emerging Class of Cancer Treatment (Deadline: 31 October 2022)
- Recent Advances in the Modulation of Cholinergic Signaling II (Deadline: 31 October 2022)
- Natural Compounds as a Potential Inhibitor to Cancer Therapy: Identification, Synthesis, In Silico and Biological Evaluation (Deadline: 31 October 2022)
- Targeted Radionuclide Diagnosis and Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives (Deadline: 31 October 2022)
- Small Molecule Hybrids for Anticancer and Antiviral Therapy (Deadline: 31 October 2022)
- Novel COVID-Related Anti-inflammatory Drugs (Deadline: 31 October 2022)
- Structural Biology Approach in Drug Discovery (Deadline: 31 October 2022)
- Targeting Oxidative Stress and Organites Associated in Disease (Deadline: 31 October 2022)
- Carbohydrate-Based Drugs Discovery (Deadline: 31 October 2022)
- Different Strategies to Overcome Multi-Drug Resistant and Persistent Infectious Diseases (Deadline: 31 October 2022)
- Novel Antimicrobial Agents: Design, Synthesis and Activity (Deadline: 31 October 2022)
- AI Driven Structural and Functional Genomics and Translational Medicine (Deadline: 31 October 2022)
- Next-Generation Physiological and Pathophysiological Hepatic In Vitro Systems for Drug, Chemical and Particulate Toxicity Testing (Deadline: 31 October 2022)
- Discovery of New Anti-cancer Molecules: From Hit Identification to Structure-Activity Relationship Study (Deadline: 31 October 2022)
- Recent Advances in Nuclear Medicine (Deadline: 31 October 2022)
- Transporter-Mediated Drug Delivery (Deadline: 1 November 2022)
- PROTACs as Dual Motif Dmall Molecule Drugs: Past, present and future of Targeted Protein Degradation in Development (Deadline: 1 November 2022)
- Past, Present and Future of Novel Therapeutic Modalities in Development for Targeted Protein Degradation (Deadline: 1 November 2022)
- Novel Metal Complexes as Potential Anticancer Agents (Deadline: 1 November 2022)
- Discovery of Anti-Inflammatory Compounds (Deadline: 1 November 2022)
- Metal-Based Complex: Preparation and Medicinal Characteristics (Deadline: 15 November 2022)
- Synthesis and Application of Opioids (Deadline: 15 November 2022)
- Recent Advances in Cardiovascular Drug Discovery and Development (Deadline: 15 November 2022)
- Polymeric Nanoparticles For Targeted Therapy (Deadline: 15 November 2022)
- Theoretical and Computational Research in Drug Discovery, Design and Development (Deadline: 20 November 2022)
- Coordination Chemistry in Cancer Therapy (Deadline: 25 November 2022)
- Discovery and Development of Small-Molecule Antitumor Drugs (Deadline: 30 November 2022)
- Cannabigerolic Acid (CBGA) from Processing to Application in Food and Life-Changing Therapeutic Medicine (Deadline: 30 November 2022)
- Synthesis and Application of Anticancer Inhibitors (Deadline: 30 November 2022)
- Heterocycles in Drugs and Drug Discovery (Deadline: 30 November 2022)
- Antiviral Agents for RNA-Virus Infection (Deadline: 30 November 2022)
- Drug-Receptor Interaction (Deadline: 30 November 2022)
- Natural Products for Cosmetic Applications (Deadline: 30 November 2022)
- New Amine Oxidase Inhibitors and Enzymes in Oxidative Stress-Related Pathologies (Deadline: 30 November 2022)
- Enzyme Inhibitors: Discovery, Synthesis and Medical Applications (Deadline: 30 November 2022)
- Novel Therapeutic Targets and Potential Drugs for Inflammatory Disease (Deadline: 30 November 2022)
- Medicinal Chemistry in Asia (Deadline: 30 November 2022)
- Bioactive Compounds for Metabolic Syndrome and Type 2 Diabetes 4.0 (Deadline: 30 November 2022)
- Multitargeting Agents for Alzheimer's Disease (Deadline: 30 November 2022)
- Current Approaches of Medicinal Chemistry in Neurological and Psychiatric Diseases (Deadline: 30 November 2022)
- Recent Advances in Antiviral Drugs Discovery (Deadline: 30 November 2022)
- Radiopharmaceuticals (Deadline: 30 November 2022)
- Potential Therapeutic Molecules for SARS-CoV-2 Three Years since the Outbreak of COVID-19 (Deadline: 30 November 2022)
- Natural Compounds: A Lead for Drug Discovery and Development (Deadline: 30 November 2022)
- Computational Studies on the Development and Characterization of Pharmaceutical Materials (Deadline: 30 November 2022)
- Chemistry and Health: Nitrogen Heterocycle Chemistry and Medicinal Chemistry (Deadline: 30 November 2022)
- Theranostic Applications of Functional Nucleic Acids (Deadline: 30 November 2022)
- Impact of Nanoparticles on Drug Delivery (Deadline: 30 November 2022)
- Anticancer Compounds with Different Biological Targets (Deadline: 30 November 2022)
- Cannabinoids for Disorders of the Nervous System: Advances and Challenges (Deadline: 30 November 2022)
- Bioactive Ingredients from Natural Products: From Therapy to Nutrition (Deadline: 30 November 2022)
- Novel Anti-inflammatory and Analgesic Agents: Synthesis, Molecular Docking and In Vivo Studies (Deadline: 30 November 2022)
- Novel Antinociceptive Agents against Persistent Pain (Deadline: 30 November 2022)
- Second Edition: Organic Synthesis in Drug Discovery (Deadline: 30 November 2022)
- Small-Molecule Inhibitors: Insights into Drug Design from Structure (Deadline: 1 December 2022)
- Design and Synthesis of Bioactive Organic Molecules (Deadline: 2 December 2022)
- Novel G-Quadruplex Ligands: From Synthesis to Evaluation (Deadline: 5 December 2022)
- Antitubercular Drug Discovery: Implication and Challenges (Deadline: 10 December 2022)
- Anticancer Drugs: Prospects and Challenges (Deadline: 15 December 2022)
- Multifunctional Imaging Materials for Biomedical Applications (Deadline: 15 December 2022)
- Microbial Natural Products in Drug Discovery Chemistry (Deadline: 15 December 2022)
- Metabolites from Algae: Discovery, Identification and Bioactive Evaluation (Deadline: 15 December 2022)
- Bioactive Compounds: Design, Synthesis and Biological Evaluation (Deadline: 15 December 2022)
- Advances in Cytoprotective Drug Discovery II (Deadline: 15 December 2022)
- Target-Specific Delivery of Gold and Ruthenium Complex to Cancer Cells: Where Are We? (Deadline: 16 December 2022)
- Cancer Metabolism as a Target for New Oncological Drugs (Deadline: 20 December 2022)
- Spirocycles in Medicinal Chemistry (Deadline: 30 December 2022)
- Recent Advance in Understanding and Treating Amyloidosis (Deadline: 30 December 2022)
- Advances on Nanomedicine and Nanoparticle-Based Drug Delivery (Deadline: 31 December 2022)
- Medicinal Chemistry in China II (Deadline: 31 December 2022)
- Designing Next-Generation Drug-Like Molecules for Medicinal Applications (Deadline: 31 December 2022)
- Exclusive Papers from the Editorial Board Members (EBMs) of the Section “Medicinal Chemistry” of Molecules (Deadline: 31 December 2022)
- Essential Oils: Antimicrobial Activities and Food Applications (Deadline: 31 December 2022)
- Anti-inflammatory Agents a Pleiotropic Bullet for Chronic Diseases (Deadline: 31 December 2022)
- Recent Advances in Anticancer Drugs III (Deadline: 31 December 2022)
- Design and Development of Novel Responsive Carrier for Drug Delivery (Deadline: 31 December 2022)
- Developing Drug Strategies for the Neuroprotective Treatment (Deadline: 31 December 2022)
- Applications of Melatonin in Health and Pathology (Deadline: 31 December 2022)
- The Chemical Immobilization and Inactivation of SARS-CoV-2 (Deadline: 31 December 2022)
- Neuroprotective Agents II (Deadline: 31 December 2022)
- Breakthroughs and Challenges in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes (Deadline: 31 December 2022)
- Antimetastatic Molecules: Perspective towards Treatment of Solid Cancers (Deadline: 31 December 2022)
- Novel Radiopharmaceuticals for PET and SPECT Imaging (Deadline: 31 December 2022)
- Advances on Bioanalysis: Recent Approaches in the Determination of Biomarkers, Drugs of Abuse and Medicines —Second Edition (Deadline: 31 December 2022)
- Pharmaceutical Analysis and Drug Stability Evaluations (Deadline: 31 December 2022)
- Small Molecule Inhibitors as Anticancer Drugs: Advances and Challenges (Deadline: 31 December 2022)
- Shaping Medicinal Chemistry for the New Decade (Deadline: 31 December 2022)
- Natural Pharmacons: Biologically Active Plant-Derived Pharmaceuticals (Deadline: 31 December 2022)
- Structural and Functional Proteomics Applied to the Biomedical Area (Deadline: 31 December 2022)
- Reactive Oxygen Species-Based Dynamic Therapy of Cancer (Deadline: 31 December 2022)
- Bioactive Ingredients in Green Tea for Human Healthcare (Deadline: 31 December 2022)
- Design, Synthesis and Biological Evaluation of Novel Heterocyclic Antitumor Compounds, 2nd Edition (Deadline: 31 December 2022)
- Discovery and Design for Novel Anti-cancer Products (Deadline: 31 December 2022)
- Small-Molecule Inhibitors of Tubulin Polymerization: Recent Advances (Deadline: 31 December 2022)
- Recent Studies on Anticancer Agents from Natural Products (Deadline: 31 December 2022)
- Targeting Cell Signaling Pathways in Anticancer Drug Design and Development (Deadline: 31 December 2022)
- Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics II (Deadline: 31 December 2022)
- Current and Novel Therapeutic Molecules for Treatment of Neuroinflammation-Mediated Neurodegenerative Disorders (Deadline: 31 December 2022)
- Bioactive Compounds for Brain Ischemia and Neurodegenerative Disease (Deadline: 31 December 2022)
- Cell-Penetrating Peptides: A Promising Tool for Drug Delivery (Deadline: 31 December 2022)
- Bioanalytical Strategies and Practices for Antibody-Drug Conjugates (Deadline: 31 December 2022)
- Molecular Docking in Drug Discovery: Methods and Applications (Deadline: 31 December 2022)
- Design, Synthesis and Structure-Activity Relationship Studies of Enzyme Inhibitors (Deadline: 31 December 2022)
- New Advances in Radiopharmaceutical Sciences: Chemistry and Applications (Deadline: 31 December 2022)
- Computational Methods in Drug Design and Discovery (Deadline: 31 December 2022)
- Recent Advances in Development of Small Molecules to Fight Cancer (Deadline: 31 December 2022)
- Novel Targeted Radiopharmaceuticals for Diagnosis and Therapy (Deadline: 31 December 2022)
- Anticancer Research: Towards an Understanding of Cancer and Discovery of New Therapeutic Agents (Deadline: 31 January 2023)
- Progress in Synthesis and Application of Heterocycles in Medicinal Chemistry (Deadline: 31 January 2023)
- Biologically Active Plant-Derived Pharmaceuticals: Recent Advances and Future Prospects (Deadline: 31 January 2023)
- Novel Antitumor Drug: Discovery and Synthesis (Deadline: 31 January 2023)
- Recent Advances in Targeted Protein Degradation (Deadline: 31 January 2023)
- Recent Advances in Nano-Based Drug Delivery System (Deadline: 31 January 2023)
- New Strategies and Drugs Against Intracellular Pathogens (Deadline: 1 February 2023)
- Forensic Analysis in Chemistry (Deadline: 28 February 2023)
- Potential Application of Peptide Nucleic Acid in Biomedical Domain (Deadline: 28 February 2023)
- Small Molecules in Targeted Cancer Therapy (Deadline: 28 February 2023)
- Innovative Computational and Experimental Approaches for Tackling Neurodegenerative Diseases (Deadline: 28 February 2023)
- Chiral Psychoactive Substances: Identification, Toxicity, and Enantioselective Studies (Deadline: 28 February 2023)
- Oxidative Stress as a Pharmacological Target for Medicinal Chemistry II (Deadline: 28 February 2023)
- Recent Advances in Bioactive Compounds from Medicinal Herbs (Deadline: 15 March 2023)
- Protein Kinase Inhibitors: Design, Specificity and Mechanism of Action (Deadline: 20 March 2023)
- Anticancer Agents: Design, Synthesis and Evaluation III (Deadline: 30 March 2023)
- Molecular Targets and Drug Discovery for Metabolic Disorders: Challenges, Recent Developments, and Prospects (Deadline: 31 March 2023)
- Chemopreventive and Antioxidant Activity of Plant Extracts and Other Phytochemical Compounds (Deadline: 31 March 2023)
- Bioactive Small Molecules: Design, Synthesis, and Applications (Deadline: 31 March 2023)
- Molecular Approaches Against Human Coronaviruses (Deadline: 31 March 2023)
- Co-Crystals as a Pharmaceutical Strategy for Altering API Physicochemical Properties (Deadline: 31 March 2023)
- Multifunctional Nanomaterials for Bioapplications (Deadline: 31 March 2023)
- Advancement in Design and Synthesis of Novel Drugs (Deadline: 30 April 2023)
- New Insights into Biomolecular Structures and Interactions (Deadline: 30 April 2023)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Antibiotics & Superbugs: New Strategies to Combat Antimicrobial Resistance
- Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes
- Efficient Pharmaceutical and Chemical Approaches for Anticancer Therapy: Design, Preliminary Evaluations, and Further Developments
- Herbal Medicine Research
- Molecular Docking
- Molecular Medicine
- Nanomedicine
- Novel Approache of Anticancer Therapy
- Poorly Soluble Drugs